Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study

• Published in: BioPsychoSocial medicine 2008-06, Vol.2 (1), p.11-11, Article 11
• Main Authors: Mikocka-Walus, Antonina A, Turnbull, Deborah A, Moulding, Nicole T, Wilson, Ian G, Holtmann, Gerald J, Andrews, Jane M
• Format: Article
• Language: English
• Subjects: Comparative analysis; Health aspects; Hepatitis C virus; Inflammatory bowel diseases; Influence; Mental illness; Patient outcomes
• ISSN: 1751-0759; 1751-0759
• DOI: 10.1186/1751-0759-2-11

Whether there is a temporal relationship between psychological problems and clinical outcomes in patients with diseases of the digestive tract has not been widely researched. Thus, our aims were 1) To observe and compare prospectively clinical outcomes in relation to psychological co-morbidity in patients with inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and chronic hepatitis C (HCV) and, 2) To test the hypothesis that patients with psychological co-morbidities are less likely to have a satisfactory response to standard treatment at 12 months. Overall, 139 patients were enrolled in this observational cohort prospective study. Over the ensuing year, physical and psychological measures were made at baseline and after 12 months (HADS, SCL90, SF-12 and disease activity measures). A logistic regression was conducted to observe any relationship between baseline characteristics and patients' clinical outcomes after 12 months. Overall, there was no relationship between psychological status and quality of life at baseline and relapse at 12 months (p > 0.05). However, patients with inactive disease at baseline were at lower risk of relapse after 12 months (OR = 0.046, CI: 0.012-0.178). No significant relationship was found between psychological problems such as depression/anxiety and a total number of relapses in the IBD group. However, interestingly, patients with an active disease at baseline tended to have a greater number of relapses (OR = 3.07, CI: 1.650-5.738) and CD participants were found at lower risk of relapse than UC participants (OR = 0.382, CI: 0.198-0.736). In contrast to previous investigations, this study suggests that there is no temporal relationship between psychological problems at baseline and clinical outcomes over time. Longer and larger prospective studies are needed to better understand this result.